Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Organovo Holdings (ONVO)

Organovo Holdings (ONVO)
2.04 x 4 2.08 x 9
Post-market by (Cboe BZX)
2.04 +0.03 (+1.49%) 04/23/25 [NASDAQ]
2.04 x 4 2.08 x 9
Post-market 2.04 unch (unch) 19:44 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.94
Day High
2.16
Open 2.16
Previous Close 2.01 2.01
Volume 244,900 244,900
Avg Vol 347,940 347,940
Stochastic %K 49.24% 49.24%
Weighted Alpha -84.58 -84.58
5-Day Change +0.38 (+22.89%) +0.38 (+22.89%)
52-Week Range 1.56 - 21.96 1.56 - 21.96
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,470
  • Shares Outstanding, K 1,701
  • Annual Sales, $ 110 K
  • Annual Income, $ -14,670 K
  • EBIT $ -13 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.13
  • Price/Sales 20.96
  • Price/Cash Flow N/A
  • Price/Book 7.17
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -10.20
  • Most Recent Earnings $-2.28 on 02/19/25
  • Next Earnings Date 05/30/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 163.01%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 902.15% on 09/04/24
  • IV Low 0.00% on 04/21/25
  • Put/Call Vol Ratio 999.99
  • Today's Volume 4
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 1,005
  • Open Int (30-Day) 1,533

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.56 +30.77%
on 04/21/25
Period Open: 3.14
3.18 -35.85%
on 03/24/25
-1.10 (-35.03%)
since 03/21/25
3-Month
1.56 +30.77%
on 04/21/25
Period Open: 4.26
21.96 -90.71%
on 02/25/25
-2.22 (-52.11%)
since 01/23/25
52-Week
1.56 +30.77%
on 04/21/25
Period Open: 12.00
21.96 -90.71%
on 02/25/25
-9.96 (-83.00%)
since 04/23/24

Most Recent Stories

More News
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market

VIVS : 1.8600 (-0.53%)
ONVO : 2.04 (+1.49%)
VivoSim to Carry Forward Organovo 3D Bioprinting

ONVO : 2.04 (+1.49%)
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements

ONVO : 2.04 (+1.49%)
Organovo Provides Business Update

LLY : 884.54 (+2.89%)
ONVO : 2.04 (+1.49%)
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company

LLY : 884.54 (+2.89%)
ONVO : 2.04 (+1.49%)
Organovo Announces Reverse Stock Split

ONVO : 2.04 (+1.49%)
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

GRCE : 2.49 (+4.62%)
ONVO : 2.04 (+1.49%)
MTNB : 0.6700 (+12.61%)
Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises

ONVO : 2.04 (+1.49%)
8 Small-Cap Stocks Surging Like Rockets After Game-Changing News

Small-cap stocks often deliver some of the most explosive gains when game-changing news hits the market. Investors searching for high-upside opportunities should pay attention to this week’s biggest...

RILY : 3.09 (-4.33%)
MLGO : 7.92 (-8.86%)
ENVB : 1.3800 (+3.39%)
RETO : 3.88 (+7.69%)
PEPG : 1.5300 (-8.93%)
STEC : 0.9380 (+0.97%)
ONVO : 2.04 (+1.49%)
GDEV : 10.38 (-4.38%)
Is Eli Lilly Stock Outperforming the Nasdaq?

Eli Lilly has outperformed the Nasdaq over the past year, and analysts are highly optimistic about the stock’s prospects.

$NASX : 17,382.94 (+1.26%)
JNJ : 154.58 (-0.23%)
LLY : 884.54 (+2.89%)
ONVO : 2.04 (+1.49%)

Business Summary

Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings,...

See More

Key Turning Points

3rd Resistance Point 2.37
2nd Resistance Point 2.27
1st Resistance Point 2.15
Last Price 2.04
1st Support Level 1.93
2nd Support Level 1.83
3rd Support Level 1.71

See More

52-Week High 21.96
Fibonacci 61.8% 14.17
Fibonacci 50% 11.76
Fibonacci 38.2% 9.35
Last Price 2.04
52-Week Low 1.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective